Cargando…

Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana

BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wynn, Adriane, Moucheraud, Corrina, Martin, Natasha K., Morroni, Chelsea, Ramogola-Masire, Doreen, Klausner, Jeffrey D., Leibowitz, Arleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663512/
https://www.ncbi.nlm.nih.gov/pubmed/34310524
http://dx.doi.org/10.1097/OLQ.0000000000001517
_version_ 1784613654294953984
author Wynn, Adriane
Moucheraud, Corrina
Martin, Natasha K.
Morroni, Chelsea
Ramogola-Masire, Doreen
Klausner, Jeffrey D.
Leibowitz, Arleen
author_facet Wynn, Adriane
Moucheraud, Corrina
Martin, Natasha K.
Morroni, Chelsea
Ramogola-Masire, Doreen
Klausner, Jeffrey D.
Leibowitz, Arleen
author_sort Wynn, Adriane
collection PubMed
description BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testing; however, cost is a barrier. METHODS: Using inputs from a pilot program in Botswana, we developed a model among a hypothetical population of 50,000 pregnant women to compare 1-year costs and outcomes associated with 3 antenatal STI testing strategies: (1) point-of-care, (2) centralized laboratory, and (3) a mixed approach (point of care at high-volume sites, and hubs elsewhere), and syndromic management. RESULTS: Syndromic management had the lowest delivery cost but was associated with the most infections at delivery, uninfected women treated, CT/NG-related low-birth-weight infants, disability-adjusted life years, and low birth weight hospitalization costs. Point-of-care CT/NG testing would treat and cure the most infections but had the highest delivery cost. Among the testing scenarios, the mixed scenario had the most favorable cost per woman treated and cured ($534/cure). Compared with syndromic management, the mixed approach resulted in a mean incremental cost-effectiveness ratio of $953 per disability-adjusted life years averted, which is cost-effective under World Health Organization's one-time per-capita gross domestic product willingness-to-pay threshold. CONCLUSIONS: As countries consider new technologies to strengthen health services, there is an opportunity to determine how to best deploy resources. Compared with point-of-care, centralized laboratory, and syndromic management, the mixed approach offered the lowest cost per infection averted and is cost-effective if policy makers' willingness to pay is informed by the World Health Organization's gross domestic product/capita threshold.
format Online
Article
Text
id pubmed-8663512
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86635122021-12-15 Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana Wynn, Adriane Moucheraud, Corrina Martin, Natasha K. Morroni, Chelsea Ramogola-Masire, Doreen Klausner, Jeffrey D. Leibowitz, Arleen Sex Transm Dis Original Studies BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testing; however, cost is a barrier. METHODS: Using inputs from a pilot program in Botswana, we developed a model among a hypothetical population of 50,000 pregnant women to compare 1-year costs and outcomes associated with 3 antenatal STI testing strategies: (1) point-of-care, (2) centralized laboratory, and (3) a mixed approach (point of care at high-volume sites, and hubs elsewhere), and syndromic management. RESULTS: Syndromic management had the lowest delivery cost but was associated with the most infections at delivery, uninfected women treated, CT/NG-related low-birth-weight infants, disability-adjusted life years, and low birth weight hospitalization costs. Point-of-care CT/NG testing would treat and cure the most infections but had the highest delivery cost. Among the testing scenarios, the mixed scenario had the most favorable cost per woman treated and cured ($534/cure). Compared with syndromic management, the mixed approach resulted in a mean incremental cost-effectiveness ratio of $953 per disability-adjusted life years averted, which is cost-effective under World Health Organization's one-time per-capita gross domestic product willingness-to-pay threshold. CONCLUSIONS: As countries consider new technologies to strengthen health services, there is an opportunity to determine how to best deploy resources. Compared with point-of-care, centralized laboratory, and syndromic management, the mixed approach offered the lowest cost per infection averted and is cost-effective if policy makers' willingness to pay is informed by the World Health Organization's gross domestic product/capita threshold. Lippincott Williams & Wilkins 2022-01 2021-08-30 /pmc/articles/PMC8663512/ /pubmed/34310524 http://dx.doi.org/10.1097/OLQ.0000000000001517 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Studies
Wynn, Adriane
Moucheraud, Corrina
Martin, Natasha K.
Morroni, Chelsea
Ramogola-Masire, Doreen
Klausner, Jeffrey D.
Leibowitz, Arleen
Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title_full Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title_fullStr Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title_full_unstemmed Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title_short Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
title_sort bridging the gap between pilot and scale-up: a model of antenatal testing for curable sexually transmitted infections from botswana
topic Original Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663512/
https://www.ncbi.nlm.nih.gov/pubmed/34310524
http://dx.doi.org/10.1097/OLQ.0000000000001517
work_keys_str_mv AT wynnadriane bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT moucheraudcorrina bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT martinnatashak bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT morronichelsea bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT ramogolamasiredoreen bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT klausnerjeffreyd bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana
AT leibowitzarleen bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana